StratDeck

Alamar Biosciences

ALMRHealthcare · Medical Devices · US
26.48USDStratDeckSEC EDGARYahoo Finance

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases.

1D−7.7%1W−14.1%1M−15.8%

Loading chart…

Checks

  • Locked: Price trend
  • Locked: Sales growth against its peers
  • Locked: Profit against similar companies
  • Locked: What analysts expect
  • Locked: Price against what it earns
  • Locked: Last quarter against forecasts

See how Alamar Biosciences does on each check. Sign in for two weeks free, with no card. Then StratDeck Pro is £5.99 a month or £60 a year.

Sign in